Skip to main content
. 2022 Dec 30;56:101810. doi: 10.1016/j.eclinm.2022.101810

Fig. 4.

Fig. 4

Changes in primary HCV incidence trends following access to DAAs by country. HCV: hepatitis C virus; DAA: direct-acting antiviral. Predicted incidence based on the linear spline model.